General Ophthalmology

1-16 of 391

KOL Knockout™: Cataract Edition — Maximizing the Use of Aberrometry, Femtosecond Lasers, and Advanced IOLs to Improve Postoperative Outcomes in Cataract Surgery
KOL Knockout™: Cataract Edition — Maximizing the Use of Aberrometry, Femtosecond Lasers, and Advanced IOLs to Improve Postoperative Outcomes in Cataract Surgery
CME/CE Broadcast Replay
KOL Knockout™: Cataract Edition — Maximizing the Use of Aberrometry, Femtosecond Lasers, and Advanced IOLs to Improve Postoperative Outcomes in Cataract Surgery
Case Studies in Dry Eye Management: Appropriate Treatment-Decisions for Your Patients
Case Studies in Dry Eye Management: Appropriate Treatment-Decisions for Your Patients
CME/CE Broadcast Replay
Case Studies in Dry Eye Management: Appropriate Treatment-Decisions for Your Patients
Preeya K. Gupta, MD; Joseph Tauber, MD
1.00 credit
- Preeya K. Gupta, MD
- Joseph Tauber, MD
1.00 credit
Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents
Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents
CME/CE Broadcast Replay
Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents
Round 3 - KOL Knockout™: Cataract Edition
Round 3 - KOL Knockout™: Cataract Edition
CME/CE Broadcast Replay
Round 3 - KOL Knockout™: Cataract Edition
Uday Devgan, MD, FACS, FRCS; David A. Goldman, MD
1.50 credits
- Uday Devgan, MD, FACS, FRCS
- David A. Goldman, MD
- Denise M. Visco, MD, MBA
- John A. Hovanesian, MD
1.50 credits
State of the Art: Photodynamic Therapy in 2022
State of the Art: Photodynamic Therapy in 2022
CME/CE Broadcast Replay
State of the Art: Photodynamic Therapy in 2022
Ocular Allergy: Incorporating Current and Emerging Treatment Options into Practice
Ocular Allergy: Incorporating Current and Emerging Treatment Options into Practice
CME/CE Broadcast Replay
Ocular Allergy: Incorporating Current and Emerging Treatment Options into Practice
CME/CE In-Person & Virtual Event
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
October 10, 2026
New Orleans, Louisiana
1.00 credit
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
CME/CE
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD; Janis T. Eells, Ph.D.
1.50 credits
- Diana V. Do, MD
- Janis T. Eells, Ph.D.
- David Boyer, MD
- Eleonora Lad, MD, PhD
- Marion R. Munk, MD, PhD
1.50 credits
Why QoL Measures Change TED Management
Why QoL Measures Change TED Management
MinuteCE®
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Designing Efficient Clinic Workflows for TED Therapy Access
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®
Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Applying CAS, EUGOGO, VISA: A Micro Case
Applying CAS, EUGOGO, VISA: A Micro Case
MinuteCE®
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Overcoming Real-World Barriers to TED Treatment 
Overcoming Real-World Barriers to TED Treatment 
MinuteCE®
Overcoming Real-World Barriers to TED Treatment 
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
MinuteCE®
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 credit 8 episodes
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 credit 8 episodes

Prev
1
2
3
…
24
25
Next

1/6